Overview

A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants

Status:
Recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, tolerability and efficacy of IC265 compared to vehicle in participants with signs and symptoms dry eye disease.
Phase:
Phase 2
Details
Lead Sponsor:
Iacta Pharmaceuticals
Treatments:
Ophthalmic Solutions
Pharmaceutical Solutions